Methylene Blue is more than a blue dye that can turn your tongue and urine blue.
It is an off-label drug with functionalized carbon nanodots.
In allopathic medicine, Methylene blue (MB) is listed as a medication used in the management and treatment of methemoglobinemia, a condition in which hemoglobin decreases its ability to carry oxygen.
Like most synthetic drugs, it congests the liver to cause liver problems which can exacerbate the problem it was supposed to resolve.
Paradoxically, at high doses, methylene blue can actually cause methemoglobinemia.
Further, its use is contraindicated in pregnant women due to fetal deaths and birth defects.
MB was only touched upon in the March 2024 blog, Pretending to Be Alternative. As the very first fully synthetic drug in western medicine, MB has been used since 1891, in the late 19th and early 20th centuries as a malarial treatment.
MB has been used for staining and characterizing malaria parasites, as a treatment for parasites, for early Alzheimer’s disease and other neurological diseases, as an antidepressant. Lately, MB has been added to skin care products as a “virus warrior.” It is also promoted to improve cognition and as a memory enhancer.
So why would you want to be wary of this ubiquitous Blue “Warrior?”
Firstly, MB like Ivermectin, is a nanostructure lipid carrier (NLC) used in drug delivery systems. This identifies Methylene Blue as a metamaterial for Artificial Intelligentsia. (AI). The introduction of lipid and nano-drug delivery systems has been used in pharma drugs since at least 1995. A 2017 study used nano lipid carriers as an Ivermectin delivery system for head lice.
Secondly, among other nano lipid carriers, MB has been posing as a wolf in sheep’s clothing, as part of a group of safe alternatives to”FDA-approved” antiviral COVID drugs.
Instead of diving into the rabbit hole of research for the pretender known as MB, watch to this review by Andrew Kaufman. Whether you like the messenger or not, the message is useful.
Related articles:
Leave A Comment